Theratechnologies (TSE:TH) is set to issue its quarterly earnings data before the market opens on Thursday, February 21st. Analysts expect the company to announce earnings of C$0.01 per share for the quarter.
Shares of TH opened at C$7.78 on Thursday. Theratechnologies has a 52 week low of C$6.72 and a 52 week high of C$14.75. The company has a market cap of $546.35 million and a P/E ratio of -65.76. The company has a current ratio of 2.89, a quick ratio of 2.40 and a debt-to-equity ratio of 137.57.
Theratechnologies Inc, a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. The company's lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada.
See Also: Quick Ratio
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.